Sander Veldhuyzen

Dec 14, 2023 | academic.oup.com | Alberta Precision Laboratories |Van Zanten |Sander Veldhuyzen

Helicobacter pylori is an accepted cause of gastritis, dyspepsia, duodenal, and gastric ulcers and is a risk factor for gastric cancer. There is consensus that H. pylori-positive patients should be offered treatment. Traditionally, therapy involved “classic” triple combinations of a proton pump inhibitor (P) with clarithromycin (C) and either amoxicillin (A) (PAC) or metronidazole (M) (PMC) for 7–14 days.